Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
Public ClinicalTrials.gov record NCT02279745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension
Study identification
- NCT ID
- NCT02279745
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- United Therapeutics
- Industry
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- Ralinepag Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2015
- Primary completion
- Mar 28, 2021
- Completion
- Mar 28, 2021
- Last update posted
- Dec 21, 2021
2015 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35249 | — |
| Cedars-Sinai Medical Center | Beverly Hills | California | 90211 | — |
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095 | — |
| University of California Davis Medical Center | Sacramento | California | 95817 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| University of Colorado Cardiac and Vascular Center, Anschutz Inpatient Pavilion | Aurora | Colorado | 80045 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Chest Medicine Associates | Portland | Maine | 04106 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Boston University Medical Center General Clinical Research Unit (GCRU) | Boston | Massachusetts | 02118 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| UC Health | Cincinnati | Ohio | 45219 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion | Columbus | Ohio | 43221 | — |
| UPMC, Presbyterian | Pittsburgh | Pennsylvania | 15229 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Memorial Hermann Hospital - Texas Medical Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02279745 live on ClinicalTrials.gov.